bluebird bio, Inc. (22)

Browse by Contract Category

Contracts

Registration Rights Agreement, dated September 7, 2021, by and between the Company and the persons listed on the attached Schedule A thereto (Filed With SEC on September 8, 2021)
Exclusive Patent License Agreement by and between the Registrant and the National Institutes of Health, dated August 31, 2015 (Filed With SEC on August 9, 2021)
Amendment No. 3 to Clinical and Commercial Supply Agreement Viral Vector Product by and between bluebird bio (Switzerland) GmbH and SAFC Carlsbad, Inc (Filed With SEC on February 23, 2021)
Description of the Registrant's Securities (Filed With SEC on February 23, 2021)
Amendment to Sublease, dated April 19, 2019, by and between the Registrant and Aventis Inc (Filed With SEC on August 1, 2019)
Employment Agreement, dated December 18, 2018, by and between Bluebird and William (Chip) Baird (Filed With SEC on February 11, 2019)
Securities Purchase Agreement, dated September 7, 2021, by and among the Company and the institutional investors named therein (Filed With SEC on September 8, 2021)
Form of Pre-Funded Warrant (Filed With SEC on September 8, 2021)
License Agreement by and between the Registrant and Biogen Idec MA Inc., dated August 13, 2014 (Filed With SEC on August 9, 2021)
Amended and Restated License Agreement by and between the Registrant and Celgene Corporation, dated February 16, 2016 (Filed With SEC on August 9, 2021)
First Amendment to Amended and Restated Co-Development, Co-Promote and Profit Share Agreement by and between the Registrant and Celgene Corporation and Celgene European Investment... (Filed With SEC on August 5, 2020)
Second Amended and Restated License Agreement by and between the Registrant and Celgene Corporation and Celgene European Investment Company LLC, dated May 8, 2020 (Filed With SEC on August 5, 2020)
Underwriting Agreement, dated as of May 18, 2020, among bluebird bio, Inc. and Goldman Sachs & Co. LLC, BofA Securities, Inc. and Cowen and Company, LLC, as representatives of the... (Filed With SEC on May 19, 2020)
Amendment Agreement No. 3 to the Toll Manufacturing and Service Agreement by and between bluebird bio (Switzerland) GmbH and Apceth Biopharma GmbH (Filed With SEC on March 12, 2020)
Description of the Registrant's Securities (Filed With SEC on February 18, 2020)
Amendment No. 2 to Clinical and Commercial Supply Agreement Viral Vector Product by and between bluebird bio (Switzerland) GmbH and SAFC Carlsbad, Inc (Filed With SEC on January 21, 2020)
Sublease, dated April 16, 2019, by and between the Registrant and Aventis Inc (Filed With SEC on August 1, 2019)
Clinical and Commercial Supply Agreement Viral Vector Product, dated November 27, 2017, by and between the Registrant and SAFC Carlsbad, Inc., as amended (Filed With SEC on August 1, 2019)
Toll Manufacturing and Service Agreement, dated November 18, 2016 by and between the Registrant and APCETH Biopharma GmbH, as amended (Filed With SEC on August 1, 2019)
Toll Manufacturing and Service Agreement, dated November 18, 2016, by and between the Registrant and APCETH Biopharma GmbH (Filed With SEC on February 21, 2019)
Clinical and Commercial Supply Agreement Viral Vector Product, dated November 27, 2017, by and between the Registrant and SAFC Carlsbad, Inc (Filed With SEC on February 21, 2019)
License Agreement, dated December 23, 2015, by and between the Registrant and SIRION Biotech GmbH (Filed With SEC on February 21, 2019)